The global COVID-19 Sample Collection Kits market was valued at $13.18 billion in 2020 and is projected to reach $21.08 billion by 2028, with a compound annual growth rate (CAGR) of 1.49% from 2021 to 2028. This growth is driven by various macro and microeconomic factors, including the expansion of business activities by emerging and smaller players in the market.
The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.
Segments covered
By Product Type (Swabs, Viral Transport Media, Blood Collection Kits, Other)
By Application (Diagnostics, Research, Other)
By End-Users (Hospitals & Clinics, Home Test, Others)
Key players
Thermo Fisher Scientific, Inc.
Hardy Diagnostics
BNTX Inc.
Formlabs
Medline Industries, Inc.
HiMedia Laboratories
Puritan Medical Products
COPAN Diagnostics
Laboratory Corporation of America Holdings
Lucence Diagnostics Pte Ltd.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook